原花青素与戊二醛共交联心脏瓣膜的相容性

马旭兵; 翟万银; 张嘉敏; 朱自严; 张红锋; 常江

原花青素与戊二醛共交联心脏瓣膜的相容性

1.
华东师范大学生命科学学院,上海 200062;
2.
中国科学研究院上海市硅酸盐研究所高性能与超微结构国家重点实验室,上海 200050;
3.
上海市血液中心,上海 200051

详细信息

中图分类号: Q819
计量
- 文章访问数: 5530
- HTML全文浏览量: 25
- PDF下载量: 2660
- 被引次数: 0
出版历程
- 收稿日期: 2012-02-01
- 修回日期: 2012-05-01
- 刊出日期: 2013-03-25

Compatibility characteristics of acellular porcine heart valve matrix co-crosslinked with procyanidins and glutaraldehyde

1.
School of Life Sciences, East China Normal University, Shanghai 200062, China;
2.
State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, China;
3.
Shanghai (Red Cross) Blood Center, Shanghai Institute of Blood Transfusion, Shanghai 200051, China

摘要

摘要: 采用8 mg/mL原花青素交联脱细胞猪主动脉心脏瓣膜4 h后，再经1.25 mg/mL戊二醛交联44 h.生物相容性检测结果显示，共交联瓣膜组细胞粘附率较戊二醛单独交联提高59%（(78.758.7)%～(19.753.27)%）、无明显溶血现象（(0.750.36)%）、血小板粘附量较戊二醛单独交联显著减少（（19315.5）个 vs (292.624.93)个）、免疫原性低（(49.336.3)% vs (95.275.26)%）. 研究结果表明，共交联瓣膜材料有良好的细胞相容性、较好的血液相容性和较低的免疫原性，是一种优良的生物瓣材料，有望应用于生物瓣制备.
- 原花青素 /
- 戊二醛 /
- 交联 /
- 心脏瓣膜 /
- 相容性
Abstract: The clinical used bioprosthetic heart valves (BHVs) were prepared from biological tissues by glutaraldehyde (GA) crosslinking. But the clinical application of BHVs is limited mainly due to calcification, cytotoxicity and remaining immunogenicity. Procyanidins (PC) can crosslink acellular heart valve matrix (AHVM) through hydrogen bond formation and prevent AHVM from calcification. The aim of this study is to modify GA crosslinking method using PC co-crosslinking to produce a much ideal material with higher compatibility for BHV preparation. Porcine aortic AHVM was crosslinked by 8 mg/mL PC for 4 h and then by 1.25 mg/mL GA for 44 h. The co-crosslinked AHVM was tested for cytocompatibility, blood compatibility and immunogenicity. The results showed that the in vitro adhesion rate of valvular interstitial cells on co-crosslinked AHVM was increased by 59% （78.75%～19.75%）when compared with that of GA-crosslinking. There was no difference in hemolysis between co- and GA- or PC-crosslinked AHVM. The co-crosslinked AHVM exhibited significant anti-thrombosis effect ((19315.5) platelets) when compared with that of GA-crosslinked ((292.624.93) platelets). Furthermore, co-crosslinked AHVM displayed lower immunogenicity than that of GA-crosslinked ((49.336.3)% vs (95.275.26)%, cell adhesive rate). These results suggest that co-crosslinked AHVM has high potential to be used for preparation of BHVs.
- procyanidins /
- glutaraldehyde /
- crosslinking /
- heart valve matrix /
- compatibility

HTML全文

参考文献(1)

[1]

［1］ JAYAKRISHNAN A, JAMEELA S R. Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices［J］. Biomaterials, 1996, 17: 471-484.

［2］ SCHOEN F J, LEVY R J. Tissue heart valves: Current challenges and future research perspectives［J］. J Biomed Mater Res, 1999, 47: 439-465.

［3］ CHANG Y, HSU C K, WEI H J, et al. Cell-free xenogenic vascular grafts fixed with glutaraldehyde or genipin: In vitro and in vivo studies［J］. J Biotechnol, 2005, 120: 207-219.

［4］ ZHAI W, L X, CHANG J, et al. Quercetin-crosslinked porcine heart valve matrix: Mechanical properties, stability, anticalcification and cytocompatibility［J］. Acta Biomater, 2010（6）: 389-395.

［5］ SCHMIDT C E，BAIER J M. Acellular vascular tissues: Natural biomaterials for tissue repair and tissue engineering［J］. Biomaterials, 2000, 21: 2215-2231.

［6］ ISENBURG J C, SIMIONESCU D T，VYAVAHARE N R. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall［J］. Biomaterials, 2005, 26: 1237-1245.

［7］ NORBERT W G, HANGORG Z, HANS H S. Nano-coating with titanium of glutaraldehyde-fixed heart valve prostheses enables a reduced immune response and a self-seeding within circulation［G］//DANIEL E. Regenerative Medicine and Tissue Engineering-Cells and Biomaterials. Rijeka: InTech,2011.

［8］ ZHAI W, CHANG J, LIN K, et al. Crosslinking of decellularized porcine heart valve matrix by procyanidins［J］. Biomaterials, 2006, 27: 3684-3690.

［9］ ZHAI W, CHANG J, L X, et al. Procyanidins-crosslinked heart valve matrix: Anticalcification effect［J］. J Biomed Mater Res B, 2009, 90B: 913-921.

［10］ FURIGA A, LONVAUD F, BADET C. In vitro study of antioxidant capacity and antibacterial activity on oral anaerobes of a grape seed extract［J］. Food Chem, 2009, 113: 1037-1040.

［11］ SIVAKUMARAN S, MOLAN A L, MEAGHER L P, et al. Variation in antimicrobial action of proanthocyanidins from Dorycnium rectum against rumen bacteria［J］. Phytochemistry, 2004, 65: 2485-2497. 

［12］ SANO T, ODA E, YAMASHITA T, et al. Anti-thrombotic effect of proanthocyanidin, a purified ingredient of grape seed［J］. Thromb Res, 2005, 115: 115-121.

［13］ LIU Y Z, CAO Y G, YE J Q, et al. Immunomodulatory effects of proanthocyanidin A-1 derived in vitro from Rhododendron spiciferum［J］. Fitoterapia, 2010, 81: 108-114.

［14］ JOHNSON C M, HANSON M N，HELGESON S C. Porcine cardiac valvular subendothelial cells in culture-cell isolation and growth-characteristics［J］. J Mol Cell Cardiol, 1987, 19: 1185-1193.

［15］ BRODBECK W G, NAKAYAMA Y, MATSUDA T, et al. Biomaterial surface chemistry dictates adherent monocyte/macrophage cytokine expression in vitro［J］. Cytokine, 2002, 18: 311-319.

［16］李相仕. 壳聚糖基生物材料与巨噬细胞相互作用研究［D］. 天津：天津大学，2007.

［17］ BLAZSO G, GABOR M，ROHDEWALD P. Antiinflammatory activities of procyanidin-containing extracts from Pinus pinaster Ait after oral and cutaneous application［J］. Pharmazie, 1997, 52: 380-382. 

［18］刘兴光，汪钢，俞世强，等．组织工程心脏瓣膜支架材料的血液相容性［J］．中国临床康复，2004，8（30）：6659-6661.

［19］ ZHOU J Y, FRITZE O, SCHLEICHER M, et al. Impact of heart valve decellularization on 3-D ultrastructure, immunogenicity and thrombogenicity［J］. Biomaterials, 2010, 31: 2549-2554.

［20］ OKAMURA K, CHIBA C, IRIYAMA T, et al. Antigen depressant effect of glutaraldehyde for aortic heterografts with a valve, with special reference to a concentration right fit for the preservation of grafts［J］. Surgery, 1980, 87: 170-176.

［21］ SIMON P, KASIMIR M T, SEEBACHER G, et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT (TM) in pediatric patients［J］. Eur J Cardio-Thorac Sur, 2003, 23: 1002-1006.

施引文献

资源附件(0)

访问统计